D. V. Jarikote et al. / Tetrahedron Letters 44 (2003) 1835–1838
1837
The reaction of OPD with acetone when performed
under similar conditions in the I.L. n-Butyl pyridinium
tetrafluoroborate showed no conversion whereas the
I.L. ethyl ammonium nitrate showed only 53% conver-
sion. The use of [bbim]BF4 and [bmim]Br gave similar
results as for [bbim]Br.
84–91; (b) Zhang, X. Y.; Xu, J. X.; Jin, S. Chin. J. Chem.
1999, 17, 404–410.
8. Reddy, K. V. V.; Rao, P. S.; Ashok, D. Synth. Commun.
2000, 30, 1825–1836.
9. Stahlofen, P.; Ried, W. Chem. Ber. 1957, 90, 815–824.
10. Ried, W.; Torinus, E. Chem. Ber. 1959, 92, 2902–2916.
11. Herbert, J. A. L.; Suschitzky, H. J. Chem. Soc., Perkin
Trans. 1 1974, 2657–2661.
The enhanced reactivity for the synthesis of the benzo-
diazepines in the imidazolium I.L. even in the absence
of a catalyst may be attributed to the inherent Brønsted
and Lewis acidities of the ring hydrogens H2, H4 and
H5 of the imidazolium cation in [bbim]Br. Previous
studies involving multi-nuclear NMR spectroscopy and
conductivity measurements for the imidazolium ions
correlating their acidity characteristics support the
above observations.22–24 Further work is in progress to
enhance the acidities of such I.L.s by incorporating
weakly coordinating anions and to study their efficacy
in promoting similar reactions.
12. Morales, H. R.; Bulbarela, A.; Contreras, R. Heterocy-
cles 1986, 24, 135–139.
13. Jung, D. I.; Choi, T. W.; Kim, Y. Y.; Kim, I. S.; Park, Y.
M.; Lee, Y. G.; Jung, D. H. Synth. Commun. 1999, 29,
1941–1951.
14. Balakrishna, M. S.; Kaboudin, B. Tetrahedron Lett. 2001,
42, 1127–1129.
15. Curini, M.; Epifano, F.; Marcotullio, M. C.; Rosati, O.
Tetrahedron Lett. 2001, 42, 3193–3195.
16. Kaboudin, B.; Navace, K. Heterocycles 2001, 55, 1443–
1446.
17. Minothora, P.; Julia, S.-S.; Constantinos, A. Tetrahedron
In conclusion, we have developed a new and efficient
method for the regioselective synthesis of 1,5-benzodi-
azepines in excellent isolated yields in short reaction
times using a room temperature ionic liquid viz.
[bbim]Br as a reaction medium for the first time.
Importantly, the I.L. not only acts as a solvating
medium but also as a promoter for the reaction giving
rise to twin advantages of ambient temperature condi-
tions and the non-requirement of a catalyst. The easy
work-up procedures, the absence of a catalyst and
recyclability of the non-volatile I.L. used as the reaction
medium makes the method amenable for scale-up
operations.
Lett. 2002, 43, 1755–1758.
18. (a) Welton, T. Chem. Rev. 1999, 99, 2071–2083; (b)
Wasserscheid, P.; Keim, W. Angew. Chem., Int. Ed. Engl.
2000, 39, 3772–3789; (c) Earle, M. J.; Seddon, K. R. Pure
Appl. Chem. 2000, 72, 1391–1398; (d) Gordon, C. M.
Appl. Catal. A: General 2001, 222, 101–117; (e) Sheldon,
R. Chem. Commun. 2001, 2399–2407.
19. (a) Deshmukh, R. R.; Rajagopal, R.; Srinivasan, K. V.
Chem. Commun. 2001, 1544–1545; (b) Rajagopal, R.;
Jarikote, A.; Dilip, V.; Srinivasan, K. V. Chem. Commun.
2002, 616–617.
20. Typical procedure:
The I.L. [bbim]Br was prepared as per the reported
procedure.19
A solution of OPD/substituted OPD 1 (4.62 mmol) and
the ketone 2 (9.72 mmol) in [bbim]Br (4.62 mmol) was
stirred at 28°C for 50 min. The completion of reaction
was followed by TLC using 30% EtOAc in petroleum
ether as eluent. After completion, the reaction mixture
was diluted with water (25 ml) and extracted with EtOAc
(2×15 ml). The combined organic layer was separated,
dried over anhydrous sodium sulphate and the solvent
evaporated under reduced pressure to afford the 1,5-ben-
zodiazepines. The products, thus isolated, were pure (sin-
gle spot on TLC). They were subjected to further
purification by chromatography through a column of
silica-gel using 20% EtOAc in petroleum ether as eluent
and fully characterized. The aqueous layer consisting of
the I.L. was subjected to distillation (80°C at 10 mmHg)
for 2 h to remove water, leaving behind the I.L. [bbim] Br
(recovery 98%), which could be recycled.
Acknowledgements
Financial assistance from DST, New Delhi (Project,
SR¯S5¯OC-23¯2002) is gratefully acknowledged.
References
1. (a) Schultz, H. Benzodiazepines; Springer: Heidelberg,
1982; (b) Smalley, R. K. In Comprehensive Organic
Chemistry; Barton, D.; Ollis, W. D., Eds.; Pergamon:
Oxford, 1979; Vol. 4, p. 600; (c) Landquist, J. K. In
Comprehensive Heterocyclic Chemistry; Katritzky, A. R.;
Rees, C. W., Eds.; Pergamon: Oxford, 1984; Vol. 1, p.
166, 170.
2. Randall, L. O.; Kappel, B. In Benzodiazepines; Garattini,
S.; Mussini, E.; Randall, L. O., Eds.; Raven Press: New
York, 1973; p. 27 and references cited therein.
21. Selected data for the new compounds 3d, 3e, 3g:
3d. Mp 92°C (found C, 84.53; H, 6.85; N, 8.62. C23H22N2
requires C, 84.63; H, 6.79; N, 8.58%); IR (cm−1) 3275
1
3. Harris, R. C.; Straley, J. M.; US Patent 1,537,757, 1968;
(NH), 1659 (CꢀN); H NMR (200 MHz, CDCl3) l 1.8 (s,
Chem. Abstr. 1970, 73, 100054w.
4. De Baun, J. R.; Pallos, F. M.; Baker, D. R.; US Patent
3,978,227, 1976; Chem. Abstr. 1977, 86, 5498d.
5. Essaber, M.; Baouid, A.; Hasnaoui, A.; Benharreb, A.;
Lavergne, J. P. Synth. Commun. 2000, 28, 4097–4105.
6. El-Sayed, A. M.; Abdel-Ghany, H.; El-Saghier, A. M. M.
Synth. Commun. 1999, 29, 3561–3572.
3H, CH3), 2.41 (s, 3H, Ar-CH3), 2.98–3.03 (d, 1H, J=13,
a
b
CH2 ), 3.13–3.17 (d, 1H, J=13, CH2 ), 3.5 (br s, 1H,
NH), 6.70–7.69 (m, 13H, Ar-H); 13C NMR (50 MHz,
CDCl3) l 164.6, 136.9, 134.0, 131.2, 130.8, 129.0, 128.6,
128.5, 128.3, 128.2, 127.4, 126.3, 125.7, 123.5, 113.5, 51.0,
45.9, 28.7, 20.9.
3e. Mp 119°C (found C, 78.54; H, 9.95; N 11.51.
C16H24N2 requires C, 78.64, H, 9.90; N, 11.46%); IR
7. (a) Xu, J. X.; Wu, H. T.; Jin, S. Chin. J. Chem. 1999, 17,